Billionaire Profile
Subbamma Jasti
Global Rank
#3048

Image: Unsplash Contributor | Unsplash License | via Unsplash

Subbamma Jasti

CEO, Pharmaceuticals
INDIA
Real-Time Net Worth
$1.072B
Estimated based on Pharmaceuticals stock value as of March 6, 2026
-0.02% (24h)
Age
92
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
INDIA

Biography

Subbamma Jasti, at 92 years old, is an Indian billionaire in the pharmaceuticals industry. She is the oldest female billionaire in India, with a net worth of $1.1 billion. Her wealth stems primarily from the sale of her stake in Suven Pharmaceuticals, which was founded by her son, Venkateswarlu Jasti. Her story exemplifies determination and strategic decision-making, making her a notable figure in the Indian business landscape.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Subbamma Jasti, a resident of Hyderabad, India, is the mother of Venkateswarlu Jasti, who co-founded Suven Pharmaceuticals in 1989. Her journey to becoming a billionaire is intertwined with her son's entrepreneurial ventures.

Rise to Success

The major source of Subbamma Jasti's wealth is derived from the sale of a substantial stake in Suven Pharmaceuticals in 2022 to Advent International. She also inherited assets from her husband, Subba Rao Jasti, who passed away in February 2023. In 2020, Suven was demerged into Suven Pharmaceuticals and Suven Life Sciences.

Key Business Strategies

Subbamma Jasti's wealth is a result of strategic investments and the success of Suven Pharmaceuticals, which her son founded. The company's sale to Advent International and her inheritance further solidified her financial standing.

Philanthropy

Specific philanthropic initiatives and amounts were not found in the search results.

Career Milestones

1989

Suven Pharmaceuticals Founded

Her son, Venkateswarlu Jasti, co-founded Suven Pharmaceuticals.

1995

Suven Pharmaceuticals Goes Public

Suven Pharmaceuticals went public.

2020

Suven Demerged

Suven Pharmaceuticals was demerged into Suven Pharmaceuticals and Suven Life Sciences.

2022

Stake in Suven Pharma Sold

Sold a stake in Suven Pharmaceuticals to Advent International.

2023

Inheritance

Inherited assets from her husband, Subba Rao Jasti, after his death.